Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
cholecalciferol 1 nephrologydiseasesdrugs
chronic kidney disease 2 nephrologydiseases
paricalcitol 1 nephrologydiseasesdrugs

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
cholecalciferol 2563 the skin by a photochemical reaction [[1]]. There are two major forms of VD, ergocalciferol (VD2) and cholecalciferol (VD3), both sharing similar metabolic pathways [[2]]. VD2 is most commonly found in vegetable sources
paricalcitol 13803 renin production in a separate group of wild type animals. Other studies have also demonstrated that paricalcitol supplementation decreases renin and renin receptor expression in animal models of CKD [[70]]. The mechanism
Select Disease Character Offset Disease Term Instance
chronic kidney disease 1345 issue with an estimated prevalence of more than a billion people worldwide. Among individuals with chronic kidney disease (CKD), VDD prevalence has been reported to be as high as 80%. Classically, VD plays a pivotal role in
chronic kidney disease 31301 1,25(OH)2-VD reenter the circulation bound to VDBP. (b) Postulated megalin and cubilin shedding in chronic kidney disease (CKD) perpetuating vitamin D deficiency (VDD) with subsequent lower 25(OH)-VD reuptake and intracrine

You must be authorized to submit a review.